Stay updated on Aptose Biosciences Press Releases

Sign up to get notified when there's something new on the Aptose Biosciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Aptose Biosciences Press Releases page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new press release entry dated Apr 30, 2026 announcing the anticipated timing of the closing of the Plan of Arrangement with Hanmi Pharmaceutical; removed an older release about Aptose’s Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML.
    Difference
    2%
    Check dated 2026-05-03T00:58:36.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Added a new press release dated Mar 31, 2026: Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights. Deleted the Sep 22, 2025 press release: Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML.
    Difference
    2%
    Check dated 2026-04-04T05:23:20.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added a new press release on Mar 23, 2026: 'Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement'. Removed an older press release from Aug 22, 2025: 'Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor'.
    Difference
    2%
    Check dated 2026-03-27T22:24:12.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a Mar 19, 2026 press release announcing that ISS recommends voting FOR the Hanmi plan of arrangement; removed the Aug 18, 2025 press release summarizing early Tuspetinib data from the TUSCANY trial.
    Difference
    2%
    Check dated 2026-03-20T17:28:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a new press release dated Feb 24, 2026: Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders. Deleted the Aug 13, 2025 entry: Aptose Reports Second Quarter 2025 Results.
    Difference
    2%
    Check dated 2026-02-27T16:20:12.000Z thumbnail image
  8. Check
    129 days ago
    Change Detected
    Summary
    Footer copyright year updated from 2025 to 2026 on the Press Releases page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-08T01:57:03.000Z thumbnail image

Stay in the know with updates to Aptose Biosciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Aptose Biosciences Press Releases page.